19 1 General introduction 50. Blaauwgeers MW, Kruip M, Beckers EAM, et al. Congenital platelet disorders and health status-related quality of life. Res Pract Thromb Haemost. 2020;4(1):100-105. doi:10.1002/rth2.12281 51. Bolton-Maggs PH, Chalmers EA, Collins PW, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006;135(5):603-33. doi:10.1111/j.1365-2141.2006.06343.x 52. Bourguignon A, Tasneem S, Hayward CP. Screening and diagnosis of inherited platelet disorders. Crit Rev Clin Lab Sci. 2022;59(6):405-444. doi:10.1080/104083 63.2022.2049199 53. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia. 2006;12 Suppl 3(s3):128-36. doi:10.1111/j.1365-2516.2006.01270.x 54. Maas DPMSM, Saes JL, Blijlevens NMA, et al. Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN study. J Thromb Haemost. 2022;20(4):833-844. doi:10.1111/jth.15652 55. Saes JL, Verhagen MJA, Meijer K, et al. Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study. Blood Adv. 2020;4(20):50255034. doi:10.1182/bloodadvances.2020002740 56. Maas DPMSM, Saes JL, Blijlevens NMA, et al. High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study. J Thromb Haemost. 2023;21(10):2726-2734. doi:10.1016/j. jtha.2023.07.014 57. Atiq F, Saes JL, Punt MC, et al. Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders. E Clinical Medicine. 2021;32:100726. doi:10.1016/j.eclinm.2021.100726 58. van Balen EC, Haverman L, Hassan S, et al. Validation of PROMIS Profile-29 in adults with hemophilia in the Netherlands. J Thromb Haemost. 2021;19(11):26872701. doi:10.1111/jth.15454 59. Kuijlaars IAR, Teela L, van Vulpen LFD, et al. Generic PROMIS item banks in adults with hemophilia for patient-reported outcome assessment: Feasibility, measurement properties, and relevance. Res Pract Thromb Haemost. 2021;5(8):e12621. doi:10.1002/rth2.12621
RkJQdWJsaXNoZXIy MTk4NDMw